Viewing Study NCT02769520


Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2025-12-26 @ 3:16 AM
Study NCT ID: NCT02769520
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-12
First Post: 2016-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
Sponsor: Assuntina G. Sacco, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module